A case of insulin and ACTH co-secretion by a neuroendocrine tumour

por Solomou, S, Khan, R, Propper, D, Berney, D, Druce, M
Publicado 2014

A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study)

por Stebbing, J, Harrison, M, Glynne-Jones, R, Bridgewater, J, Propper, D
Publicado 2008

Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane

por Anderson, H, Yap, J T, Wells, P, Miller, M P, Propper, D, Price, P, Harris, A L
Publicado 2003

A phase II study of bryostatin 1 in metastatic malignant melanoma.

por Propper, D. J., Macaulay, V., O'Byrne, K. J., Braybrooke, J. P., Wilner, S. M., Ganesan, T. S., Talbot, D. C., Harris, A. L.
Publicado 1998

Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbaz...

por Propper, D J, Braybrooke, J P, Levitt, N C, O'Byrne, K, Christodoulos, K, Han, C, Talbot, D C, Ganesan, T S, Harris, A L
Publicado 2000

A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer

por Madhusudan, S, Protheroe, A, Propper, D, Han, C, Corrie, P, Earl, H, Hancock, B, Vasey, P, Turner, A, Balkwill, F, Hoare, S, Harris, A L
Publicado 2003

The effect of anti-cancer therapy on immunological response to COVID-19 vaccination

por Jackson-Spence, F.E., Toms, C., Yang, Y-H., Walshaw, L., Caldwell, L., Riddell, A., Cutino-Moguel, M-T., Szabados, B., Propper, D., Powles, T.
Publicado 2022

Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer

por Levitt, N C, Propper, D J, Madhusudan, S, Braybrooke, J P, Echeta, C, te Poele, R, Davies, S L, Flanagan, E, Hickson, I D, Joel, S, Ganesan, T S
Publicado 2005

Weak-coupling superconductivity in a strongly correlated iron pnictide

por Charnukha, A., Post, K. W., Thirupathaiah, S., Pröpper, D., Wurmehl, S., Roslova, M., Morozov, I., Büchner, B., Yaresko, A. N., Boris, A. V., Borisenko, S. V., Basov, D. N.
Publicado 2016

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

por O'Byrne, K J, Dobbs, N, Propper, D J, Braybrooke, J P, Koukourakis, M I, Mitchell, K, Woodhull, J, Talbot, D C, Schally, A V, Harris, A L
Publicado 1999

Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer

por Propper, D J, Levitt, N C, O'Byrne, K, Braybrooke, J P, Talbot, D C, Ganesan, T S, Thompson, C H, Rajagopalan, B, Littlewood, T J, Dixon, R M, Harris, A L
Publicado 2000

Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha

por Braybrooke, J P, Propper, D J, O’Byrne, K J, Koukourakis, M I, Patterson, A V, Houlbrook, S, Love, S D, Varcoe, S, Taylor, M, Ganesan, T S, Talbot, D C, Harris, A L
Publicado 2000

Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma

por Corrie, P. G., Qian, W., Basu, B., Valle, J. W., Falk, S., lwuji, C., Wasan, H., Palmer, D., Scott-Brown, M., Wadsley, J., Arif, S., Bridgewater, J., Propper, D., Gillmore, R., Gopinathan, A., Skells, R., Bundi, P., Brais, R., Dalchau, K., Bax, L., Chhabra, A., Machin, A., Dayim, A., McAdam, K., Cummins, S., Wall, L., Ellis, R., Anthoney, A., Evans, J., Ma, Y. T., Isherwood, C., Neesse, A., Tuveson, D., Jodrell, D. I.
Publicado 2020